X2KG0FBBypass Hepatic Vein using Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Open Approach, New Technology Group 11

New Technology›Cardiovascular System›Bypass
ICD-10-PCS X2KG0FB
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

X2KG0FB is a billable ICD-10-PCS procedure code for Bypass Hepatic Vein using Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Open Approach, New Technology Group 11. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRGs 228, 229. The root operation Bypass involves altering the route of passage of the contents of a tubular body part.

Code Identity

ICD-10-PCS Code
X2KG0FB
Billable Status
Yes — Valid for Submission
Code Describes
Bypass Hepatic Vein using Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Open Approach, New Technology Group 11
Short Description
Bypass Hep Vn w Aut Cel Seed Resrb Scafld, Open, New Tech 11
Parent Code
X2K New Technology, Cardiovascular System, Bypass

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body System2Cardiovascular System
3OperationKBypass
4BodyPartGHepatic Vein
5Approach0Open
6Device/Substance/TechnologyFAutologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery
7QualifierBNew Technology Group 11

In the ICD-10-PCS Alphabetic Index

These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:

Bypass, Conduit through Femoral Vein to Popliteal Artery
Leads to this code's table
Conduit through Femoral Vein to Popliteal Artery, Bypass
Leads to this code's table
Bypass, Conduit through Femoral Vein to Superficial Femoral Artery
Leads to this code's table
Conduit through Femoral Vein to Superficial Femoral Artery, Bypass
Leads to this code's table
New Technology, Bypass, Conduit through Femoral Vein to Popliteal Artery
Leads to this code's table
New Technology, Bypass, Conduit through Femoral Vein to Superficial Femoral Artery
Leads to this code's table
Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Bypass
Leads to this code's table
Bypass, Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery
Leads to this code's table
New Technology, Bypass, Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery
Leads to this code's table

To code conduit through femoral vein to popliteal artery of the bypass, open the FY 2027 ICD-10-PCS Alphabetic Index at Conduit through Femoral Vein to Popliteal Artery, then the subterm Bypass. The index leads to table X2K, where the approach, Device/Substance/Technology and qualifier values shown in the breakdown above complete the seven-character code X2KG0FB.

Browse the full ICD-10-PCS Alphabetic Index →

Code History

FY 2027New code, effective October 1, 2026.
Replaces previously assigned code(s):
  • 061007P — Bypass Inf Vena Cava to Pulm Trunk w Autol Sub, Open
  • 061007Q — Bypass Inf Vena Cava to R Pulm Art w Autol Sub, Open
  • 061007R — Bypass Inf Vena Cava to L Pulm Art w Autol Sub, Open

Similar Procedure Codes

Questions About X2KG0FB

Is X2KG0FB a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Bypass Hepatic Vein using Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Open Approach, New Technology Group 11 on inpatient claims from October 1, 2026 through September 30, 2027.

What do the characters in X2KG0FB mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character 2 is the Body System (Cardiovascular System); the 3rd character K is the Operation (Bypass); the 4th character G is the BodyPart (Hepatic Vein); the 5th character 0 is the Approach (Open); the 6th character F is the Device/Substance/Technology (Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery); the 7th character B is the Qualifier (New Technology Group 11).

What MS-DRG does X2KG0FB group to?

On an inpatient stay, Bypass Hepatic Vein using Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Open Approach, New Technology Group 11 maps to MS-DRGs 228, 229, with relative weights from 3.4404 to 4.9660. The MS-DRG sets the fixed Medicare payment for the stay.